MIGRAINE WITHOUT AURA

This study will test two FDA-approved migraine drugs, rimegepant (a tablet that dissolves on the tongue) and zavegepant (a nasal spray), in 100 adults visiting the emergency department for a migraine. The goal is to see if these drugs provide pain relief within 2 hours without ne…

This study looks at people with migraines who also have a small hole in the heart (PFO). Participants first take a blood-thinning drug (prasugrel) to see if their migraines improve. Those who respond are randomly assigned to either continue the drug alone or have a procedure to c…

This study tests whether using a virtual reality headset to practice a type of mindfulness therapy called Acceptance and Commitment Therapy (ACT) can reduce migraine-related disability. About 160 adults with episodic migraine will either continue their usual care or add VR sessio…

This study will test whether a smartphone app called Health enSuite Migraine can help people aged 18 to 50 reduce how often they get migraine headaches. The app teaches simple techniques like managing triggers, relaxing, and changing negative thoughts. About 415 Canadian adults w…

This study tests whether adding gentle eye muscle techniques to standard neck and jaw manual therapy can reduce pain and disability in people with migraine without aura. Eighty-four adults aged 18–65 will receive six physiotherapy sessions over eight weeks. Half will get the comb…

This study gives a natural brain chemical called adrenomedullin to 26 people with migraines to see if it triggers an attack. Participants first receive a migraine-preventing drug (erenumab) to block related receptors. The goal is to understand how migraines start, not to test a n…

This study looks at whether pramlintide, a drug similar to the hormone amylin, can cause migraine attacks in people who get migraines without aura. Researchers will give 21 participants either pramlintide or a placebo and watch for headaches over 12 hours. The goal is to understa…